Submission date
31/03/2008
Registration date
29/04/2008
Last edited
20/09/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Konstantinos Dabos

ORCID ID

Contact details

Helenas Venizelou 2
Chios
821-00
Greece
kostasophia@yahoo.com

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

MGHP05

Study information

Scientific title

Acronym

MGHP

Study hypothesis

Mastic gum is effective in eradicating Helicobacter pylori in vivo.

Ethics approval(s)

Ethics approval received from the Greek Medicines Agency Ethics Board on the 18th December 2005 (ref: MGCGH0032/06).

Study design

Randomised controlled trial with three arms

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Helicobacter pylori gastritis

Intervention

Patients positive to Helicobacter pylori will be randomised to receive one of the following:

1. Mastic gum 2 g per day for 14 days
2. Mastic gum 2 g per day and pantoprazole 40 mg per day for 14 days
3. Pantoprazole 40 mg per day, amoxicillin 2 g per day and clarithromycin 1 g per day for 10 days

Follow up was two months after the end of the treatment for all study arms.

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Not Specified

Drug/device/biological/vaccine name(s)

Mastic gum, pantoprazole, amoxicillin, clarithromycin

Primary outcome measure

Eradication of Helicobacter pylori, measured at five weeks after the end of treatment.

Secondary outcome measures

Helicobacter pylori load in patients remaining H. pylori positive, measured at five weeks after the end of treatment.

Overall study start date

01/12/2006

Overall study end date

01/06/2007

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Patients tested positive for H. pylori
2. Adults of either sex aged between 18 and 75 years of age

Participant type(s)

Patient

Age group

Adult

Lower age limit

18 Years

Upper age limit

75 Years

Sex

Both

Target number of participants

42

Participant exclusion criteria

1. Pregnancy
2. Malignancy
3. Allergies to pantoprazole, amoxicillin, clarithromycin

Recruitment start date

01/12/2006

Recruitment end date

01/06/2007

Locations

Countries of recruitment

Greece

Study participating centre

Helenas Venizelou 2
Chios
821-00
Greece

Sponsor information

Organisation

The Chios Mastic Gum Producers Cooperative (Greece)

Sponsor details

Konstantinou Monomahou 1
Chios
821-00
Greece

Sponsor type

Industry

Website

http://www.gummastic.gr

ROR

https://ror.org/05rpby975

Funders

Funder type

Industry

Funder name

The Chios Mastic Gum Producers Cooperative (Greece)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2010 Yes No

Additional files

Editorial Notes